Page 497 - Read Online
P. 497

Page 6 of 10                                          Zein et al. Plast Aesthet Res 2020;7:44  I  http://dx.doi.org/10.20517/2347-9264.2020.133

               Table 1. Summary of hyaluronic acid dermal fillers currently commercially available in the United States
                Product                    Site          [HA] (mg/mL)        G' (Pa)       Duration (months)
                Belotero Balance    Superficial - mid-dermis  22.5            30                6
                Restylane-L         Superficial - mid-dermis  20              565               6
                Restylane           Medium - deep            20               544               9
                Restylane Silk      Superficial - sub-mucosal  20             344               6
                Restylane Lyft      Medium - deep            20               545               9
                Restylane Refyne    Medium - deep            20               47                12
                Restylane Defyne    Medium - deep            20               260               12
                Restylane Kysse     Superficial- sub-mucosal  20              156               12
                Juvéderm Ultra XC   Superficial - medium     24               207               12
                Juvéderm Volbella XC  Superficial - medium   15               274               12
                Juvéderm Vollure XC  Medium - deep           17.5             317               18
                Juvéderm Voluma XC  Medium - deep            20               353               24
                Juvéderm Ultra Plus XC  Medium - deep        24               244               12
                Revanesse Versa Plus  Medium - deep          28               130               12
                Teosyal RHA 2       Superficial - mid-dermis  23              144               15
                Teosyal RHA 3       Medium - deep            23               184               15
                Teosyal RHA 4       Deep - sub-cutaneous     23               296               15
               [HA]: concentration of hyaluronic acid, G’: elastic modulus. Values were obtained from manufacturer documentation and published
               sources [56-60] . Exact G’ values varied between sources, but the relative differences between listed products were similar

               be rapidly applied, and if available the patient can be referred for hyperbaric oxygen. Few reports suggest
               sodium thiosulfate can be used to dissolve calcium hydroxylapatite [39,40] . However, apart from injection of
                                                                 [41]
               hyaluronidase, no other therapy has been proven effective . There is no consensus on how to treat vision
               loss from filler-associated vascular occlusion, though anterior chamber paracentesis, ocular massage,
               hyperbaric oxygen and retrobulbar hyaluronidase injection have all been tried [37,42] . Fortunately, with proper
               attention to anatomy vascular complications are exceedingly rare.


               AVOIDING BAD COSMETIC OUTCOMES
               Strategies for filler placement
               There are four basic injection techniques associated with dermal fillers. The most basic technique is
               threading, which involves the application of a continuous line of filler injected in a retrograde fashion to
               correct discrete rhytids. The crosshatching technique builds upon this and involves continuous overlapping
               horizontal and vertical lines to build volume. The third technique is fanning, which involves drawing
               filler lines in a fan-shaped projection. Finally, serial puncture involves the injection of discreet aliquots of
               product to correct deep deformities.

               Irregular surface contours
               Superficial irregularities are commonly encountered in regions with minimal subcutaneous fat. To avoid
               this complication, filler must be placed deeply. In the tear trough region, we use a serial puncture technique
               to advance the needle to the periosteum along the inferior orbital rim and deliver small boluses of product
               working from medial to lateral. Similarly, in the temporalis fossa, we inject deeply under the fascia of
               the temporalis muscle in the area of maximal volume loss attempting to avoid vessels and nerves while
               providing a nice contour. In areas that require more superficial injection such as along the nasolabial
                                                                                              [43]
               groove, using hyaluronic acid fillers with higher cohesivity will diminish surface irregularities . Any lumps
               or bumps noticed early on are addressed with manual massage, while persistent irregularities generally
               must be dissolved with hyaluronidase.

               Festoons
               Festoons or chronic fluid collections often become more noticeable following filler injection with
               particular hydrophilic hyaluronic acids. Tear trough filler is particularly prone to this complication and it
   492   493   494   495   496   497   498   499   500   501   502